SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in OCS — Oculis Holding AG

CIK 1446194 BALA CYNWYD, PA

Back to OCS Full portfolio

Position in OCS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$171,030

+$171,030 QoQ

Shares Held

12,331

+2.7% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 59 holders

Holding Since

Mar 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCS Over Time

Shares Held

Position Value (USD)

Derivatives in OCS

reported options exposure · as of Jun 30, 2026

CallValue

$348,137

CallShares

25,100

PutValue

$177,536

PutShares

12,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. OCS ranks #244 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,053,896	$140,442,180
2	CYTK	Cytokinetics Inc	1,549,458	$131,998,327
3	REGN	Regeneron Pharmaceuticals, Inc.	180,219	$112,373,755
4	ALNY	Alnylam Pharmaceuticals, Inc.	294,460	$88,641,293
5	MDGL	Madrigal Pharmaceuticals, Inc.	148,610	$79,796,139
6	INSM	INSMED Inc	729,354	$77,763,723
7	VRTX	Vertex Pharmaceuticals Inc / Ma	144,174	$71,615,550
8	AGIO	Agios Pharmaceuticals, Inc.	1,375,558	$51,046,957

All Filings in OCS

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$348,137	25,100	—	Call	Other	2026-08-14
2026-06-30	$177,536	12,800	—	Put	Other	2026-08-14
2026-06-30	$171,030	12,331	—	Shares	Other	2026-08-14
2025-03-31 OCSAW	—	12,007	—	Shares	Other	2025-05-14
No filing history on record for this holder in this stock.